Mirtti T - Search Results

1

New prostate cancer grade grouping system predicts survival after radical prostatectomy.

Erickson A, Sandeman K, Lahdensuo K, Nordling S, Kallajoki M, Seikkula H, Bützow A, Vasarainen H, Boström PJ, Taimen P, Rannikko A, Mirtti T. Erickson A, et al. Among authors: mirtti t. Hum Pathol. 2018 May;75:159-166. doi: 10.1016/j.humpath.2018.01.027. Epub 2018 Feb 13. Hum Pathol. 2018. PMID: 29447924 Free article. No abstract available.

2

Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions.

Mirtti T, Kallajoki M, Aaltonen M, Alanen K. Mirtti T, et al. Anal Quant Cytol Histol. 2001 Jun;23(3):229-37. Anal Quant Cytol Histol. 2001. PMID: 11444193

3

Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.

Mirtti T, Alanen K, Kallajoki M, Rinne A, Söderström KO. Mirtti T, et al. Prostate. 2003 Mar 1;54(4):290-8. doi: 10.1002/pros.10196. Prostate. 2003. PMID: 12539227

4

Regulation of prostate cell collagen receptors by malignant transformation.

Mirtti T, Nylund C, Lehtonen J, Hiekkanen H, Nissinen L, Kallajoki M, Alanen K, Gullberg D, Heino J. Mirtti T, et al. Int J Cancer. 2006 Feb 15;118(4):889-98. doi: 10.1002/ijc.21430. Int J Cancer. 2006. PMID: 16152594 Free article.

5

Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.

Mirtti T, Laine VJ, Hiekkanen H, Hurme S, Rowe O, Nevalainen TJ, Kallajoki M, Alanen K. Mirtti T, et al. APMIS. 2009 Mar;117(3):151-61. doi: 10.1111/j.1600-0463.2008.00002.x. APMIS. 2009. PMID: 19245588

6

Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre.

Boström PJ, Mirtti T, Kössi J, Laato M, Nurmi M. Boström PJ, et al. Among authors: mirtti t. Scand J Urol Nephrol. 2009;43(5):357-64. doi: 10.3109/00365590902939387. Scand J Urol Nephrol. 2009. PMID: 19921979

7

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.

Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Mirtti T, Alanen K, Kallajoki M, Vuoristo MS, Pyrhönen S, Heino J. Rappu P, et al. Among authors: mirtti t. Int J Cancer. 2011 May 15;128(10):2382-92. doi: 10.1002/ijc.25571. Int J Cancer. 2011. PMID: 20658534 Free article.

8

Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.

Boström PJ, Alkhateeb S, Trottier G, Athanasopoulos PZ, Mirtti T, Kortekangas H, Laato M, van Rhijn B, van der Kwast T, Fleshner NE, Jewett MA, Finelli A, Zlotta AR. Boström PJ, et al. Among authors: mirtti t. BJU Int. 2012 Jan;109(1):70-6. doi: 10.1111/j.1464-410X.2011.10371.x. Epub 2011 Aug 18. BJU Int. 2012. PMID: 21851540

9

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.

Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J, Vesterinen T, Nordling S, Kallioniemi O, Hautaniemi S, Jänne OA. Sahu B, et al. Among authors: mirtti t. EMBO J. 2011 Sep 13;30(19):3962-76. doi: 10.1038/emboj.2011.328. EMBO J. 2011. PMID: 21915096 Free PMC article.

10

Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.

Björkman M, Östling P, Härmä V, Virtanen J, Mpindi JP, Rantala J, Mirtti T, Vesterinen T, Lundin M, Sankila A, Rannikko A, Kaivanto E, Kohonen P, Kallioniemi O, Nees M. Björkman M, et al. Among authors: mirtti t. Oncogene. 2012 Jul 19;31(29):3444-56. doi: 10.1038/onc.2011.512. Epub 2011 Nov 28. Oncogene. 2012. PMID: 22120715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page